image

Philip-Santangelo-mRNA-Cancer-Gene-Modulation-ARPA-H.jpeg

Primary tabs

  Researchers, from left, Lorena Chaves, Jose Assumpcao, and Philip Santangelo will be part of a collaborative effort to use mRNA drugs to enhance the body’s immune response. Santangelo is leading the $24 million project supported by the federal Advanced Research Projects Agency for Health. (Photo: Jack Kearse)

Researchers, from left, Lorena Chaves, Jose Assumpcao, and Philip Santangelo will be part of a collaborative effort to use mRNA drugs to enhance the body’s immune response. Santangelo is leading the $24 million project supported by the federal Advanced Research Projects Agency for Health. (Photo: Jack Kearse)